Prognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma

Table 1

Relationship between miR-210 expression and clinicopathological factors.

Clinicopathological factor	Patient number	miR-210 miRNA expression
		High group	Low group
Gender				0.258
Male	46	26	20
Female	34	14	20
Age				0.222
≤65	24	9	15
≥66	56	31	25
Tumor size				0.82
<30 mm	48	23	25
≥30 mm	32	17	15
T factor				0.481
T1-T2	61	34	37
T3-T4	9	6	3
Lymph node				0.293
Negative	61	28	33
Positive	19	12	7
P-stage				0.232
Stage I	54	24	30
Stages II-III	26	16	10
ly factor				0.502
Negative	41	19	22
Positive	39	21	17
v factor				0.359
Negative	43	22	27
Positive	27	18	13
Relapse				0.007
With	37	25	12
Without	43	15	28

Relapse was defined as first evidence of radiographic metastatic disease after surgery.
< 0.05.